Pfizer

Pfizer is set to acquire Seagen for $43 billion and create a new oncology division

Pfizer is set to acquire Seagen for $43 billion and create a new oncology division

13 Dec 2023

In a significant move, Pfizer has announced its anticipation of concluding the $43 billion deal to acquire cancer drug maker Seagen by 16 December 2023.

Moderna sues Pfizer-BioNtech for patent violation

02 Sep 2022

According to Moderna, Pfizer-BioNTech copied mRNA technology that Moderna had patented between 2010 and 2016, well before Covid-19 emerged in 2019

Pfizer to boost respiratory drug portfolio with ReViral purchase

08 Apr 2022

Pfizer eyes a market gatecrash as India’s Covid tally mounts

04 May 2021

US pharma giant Pfizer is trying to convince Indian authorities that there is no need for regulatory scrutiny for its corona virus vaccine that added $3.5 billion to its revenue in the first three months of this year, since it is approved by regulatory authorities in the US, Britain, Japan and the WHO, all of which India endorses

Pfizer defers India release of Covid-19 vaccine for want of clinical data

08 Feb 2021

Over 12,400 people in Israel test Covid-19 positive after taking Pfizer vaccine

25 Jan 2021

Covid-19 vaccine jab leaves 23 dead in Norway, 10 in Germany

21 Jan 2021

Pfizer seeks clinical trial waiver for emergency marketing approval in India

09 Dec 2020

UK authorises emergency use of Pfizer-BioNTech Covid-19 vaccine

08 Dec 2020

Pfizer to acquire cancer drug maker Array Biopharma for $10.6 bn

18 Jun 2019

Array’s Braftovi and Mektovi, launched last July for the deadliest form of skin cancer at a price of $22,000 per month, had sales of around $72 million over their first nine months, besides revenue from royalty and licensing deals

CCI approves GSK-Pfizer consumer healthcare JV

24 May 2019

Pfizer to shutter two more plants in India

09 Jan 2019

GlaxoSmithKline backs out of bidding for Pfizer’s consumer unit

23 Mar 2018

GlaxoSmithKline has pulled out of bidding for the consumer healthcare business of Pfizer, days after Reckitt Benckiser’s backed out

Pfizer to end Alzheimer, Parkinson research; patients disappointed

17 Jan 2018

Pfizer to end research to develop new drugs for Alzheimer’s and Parkinson’s disease

09 Jan 2018

Pfizer, J&J in legal battle that could shape biosimilars market

21 Sep 2017

Pfizer secures Indian patent for its pneumonia vaccine

23 Aug 2017

Pfizer's patent on the same vaccine was revoked by the European Patent Office last year, and is being challenged in the United States and South Korea

FDA approves Pfizer's Bespona for treatment of acute lymphoblastic leukemia

18 Aug 2017

US FDA approves Merck KGaA and Pfizer drug for rare skin cancer

25 Mar 2017

Advent withdraws from bidding for Pfizer's Brazilian generic drugs joint venture

24 Mar 2017

Pfizer explores sale of some treatment drugs worth over $2 bn

03 Feb 2017

As a part of its plan to raise cash and streamline its portfolio, Pfizer will sell its cardiology, urology and primary care treatment drugs

After Pfizer, Actavis accused of hiking drug price by 12,000%

17 Dec 2016

A week after Pfizer was slapped with a record fine of £84.2 million for unfair price hikes, the UK’s Competition and Markets Authority has accused Actavis of hiking the price of a drug from 70p to £88 a pack

Pfizer fined for 2,600% price hike

08 Dec 2016

Pfizer offers discounted Prevnar 13 for humanitarian programmes

12 Nov 2016

Novartis to take on Pfizer’s Ibrance with Ribociclib for breast cancer

10 Oct 2016

View details about the software product Informachine News Trackers